Review: It All Begins
15/03/2022 - Frédéric Choffat’s latest feature thrusts us up close and personal to a generation who are fighting to survive in a world that’s falling apart
Stay updated with breaking news from Solothurn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
15/03/2022 - Frédéric Choffat’s latest feature thrusts us up close and personal to a generation who are fighting to survive in a world that’s falling apart
Biogen (BIIB) and Eisai (ESALY) (ESALF) amended their collaboration agreement on Alzheimer's therapy Aduhelm (aducanumab) giving sole global commercialization rights to...
Biogen and Eisai have revised their current partnership agreements on Alzheimer's disease (AD) therapies, aducanumab and lecanemab.
Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023Lecanemab collaboration to continue unchanged globallyLecanemab